|
Status |
Public on Jan 05, 2011 |
Title |
Expression data from rapamycin treatment and/or p73 knock-down in Rh30 cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
p73 is a p53 family transcription factor that plays critical roles during development and tumor suppression. We analyzed p73 activity using a combination of ChIP-on-Chip and gene expression profiling, both at baseline and after treatment with the mTOR inhibitor rapamycin. We generated an mTOR-p73 gene signature that predicts rhabdomyosarcoma tumor subtype and patient outcome, and is enriched for p73 target genes involved in mesenchymal stem cell differentiation and tumorigenesis.
|
|
|
Overall design |
Rh30 rhabdomyosarcoma cells were infected with lentivirus (either control or expressing one of two RNAi constructs targeting p73) for 3 d, and treated with vehicle or 40 nM rapamycin for 24 h, and then total RNA was harvested. Experiments were performed in duplicate for a total of 8 samples. For p73 RNAi, a different targeting construct was used for each replicate.
|
|
|
Contributor(s) |
Rosenbluth JM, Pietenpol JA |
Citation(s) |
21245298 |
|
Submission date |
Apr 16, 2009 |
Last update date |
Jul 26, 2018 |
Contact name |
Jennifer Pietenpol |
Organization name |
Vanderbilt University Medical Center
|
Department |
Biochemistry
|
Lab |
652 PRB
|
Street address |
23rd Ave South at Pierce
|
City |
Nashville |
State/province |
TN |
ZIP/Postal code |
37232 |
Country |
USA |
|
|
Platforms (1) |
GPL6244 |
[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] |
|
Samples (8)
|
GSM393164 |
Vehicle control, sh p73-2, B |
GSM393165 |
40 nM rapamycin, sh GFP, A |
GSM393166 |
40 nM rapamycin, sh GFP, B |
GSM393167 |
40 nM rapamycin, sh p73-1, A |
GSM393168 |
40 nM rapamycin, sh p73-2, B |
|
This SubSeries is part of SuperSeries: |
GSE15719 |
p73 activity and rapamycin treatment: ChIP-on-Chip and gene expression profiling studies |
|
Relations |
BioProject |
PRJNA123021 |